Inhibitors of Platelet Glycoprotein IIb/IIIa Receptors

This publication has 18 references indexed in Scilit:

• Angiographic progression of coronary artery disease and the development of myocardial infarction
  Published by Elsevier ,2004
• Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular Medicine
  New England Journal of Medicine, 1995
• Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
  Journal of Clinical Investigation, 1994
• Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months
  The Lancet, 1994
• Hantavirus Pulmonary Syndrome: A Clinical Description of 17 Patients with a Newly Recognized Disease
  New England Journal of Medicine, 1994
• Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris.
  Journal of Clinical Investigation, 1990
• A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.
  Journal of Clinical Investigation, 1985
• Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries.
  Circulation, 1984
• Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic Death
  New England Journal of Medicine, 1984
• Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart Disease
  New England Journal of Medicine, 1981